Concepedia

A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis

Michael J. Borucki, John Spritzler, David M. Asmuth, J. W. Gnann, M HIRSCH, Mostafa Nokta, Francesca Aweeka, P NADLER, F Sattler, Beverly Alston

Antiviral Research · 2004 · 11 citations · 0 references

Concepts

Life SciencesImmunologyInfectious DiseasesImmunology Of Infectious DiseasesMonoclonal AntibodiesVirologyAntiretroviral TherapyAntiviral ImmunityAntiviral PharmacotherapyAntiviral TherapyMonoclonal Antibody TherapyViral InfectionsCytomegalovirus DiseaseCytomegalovirus Infection ManagementCytomegalovirus TherapyInfectious RetinitisPhase Ii InvestigationPlacebo-controlled Efficacy AssessmentTreatment Of Cytomegalovirus Infection